US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
US20030068362A1
(en)
*
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
US6096331A
(en)
*
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US6179817B1
(en)
|
1995-02-22 |
2001-01-30 |
Boston Scientific Corporation |
Hybrid coating for medical devices
|
US6774278B1
(en)
|
1995-06-07 |
2004-08-10 |
Cook Incorporated |
Coated implantable medical device
|
CN1304058C
(zh)
*
|
1996-03-12 |
2007-03-14 |
Pg-Txl有限公司 |
水溶性紫杉醇产品
|
US6441025B2
(en)
|
1996-03-12 |
2002-08-27 |
Pg-Txl Company, L.P. |
Water soluble paclitaxel derivatives
|
ATE310538T1
(de)
*
|
1996-04-15 |
2005-12-15 |
Asahi Chemical Ind |
Arzneimittelkomplexe enthaltend taxan- verbindungen oder steroiden
|
US6030941A
(en)
*
|
1996-05-01 |
2000-02-29 |
Avi Biopharma, Inc. |
Polymer composition for delivering substances in living organisms
|
WO1997040854A2
(en)
*
|
1996-05-01 |
1997-11-06 |
Antivirals Inc. |
Polypeptide conjugates for transporting substances across cell membranes
|
CN1219872A
(zh)
*
|
1996-05-24 |
1999-06-16 |
血管技术药物公司 |
治疗或预防身体通道疾病的组合物和方法
|
US20070092563A1
(en)
*
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
GB9708265D0
(en)
*
|
1997-04-24 |
1997-06-18 |
Nycomed Imaging As |
Contrast agents
|
US6515016B2
(en)
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
US20030157187A1
(en)
*
|
1996-12-02 |
2003-08-21 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing inflammatory diseases
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
DE69734362T2
(de)
|
1996-12-03 |
2006-07-20 |
Sloan-Kettering Institute For Cancer Research |
Synthese von epothilonen, zwischenprodukte dazu, analoga und verwendungen davon
|
US6204388B1
(en)
|
1996-12-03 |
2001-03-20 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
US7112338B2
(en)
*
|
1997-03-12 |
2006-09-26 |
The Regents Of The University Of California |
Cationic liposome delivery of taxanes to angiogenic blood vessels
|
DE19718339A1
(de)
*
|
1997-04-30 |
1998-11-12 |
Schering Ag |
Polymer beschichtete Stents, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
|
JP2002502376A
(ja)
|
1997-05-21 |
2002-01-22 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ |
生物学的膜を横切る輸送を増強するための組成物および方法
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
US6306166B1
(en)
*
|
1997-08-13 |
2001-10-23 |
Scimed Life Systems, Inc. |
Loading and release of water-insoluble drugs
|
DE19744135C1
(de)
*
|
1997-09-29 |
1999-03-25 |
Schering Ag |
Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
|
US20040170563A1
(en)
*
|
1997-10-27 |
2004-09-02 |
Meade Thomas J. |
Magnetic resonance imaging agents for the delivery of therapeutic agents
|
US6485514B1
(en)
*
|
1997-12-12 |
2002-11-26 |
Supergen, Inc. |
Local delivery of therapeutic agents
|
HUP0102473A3
(en)
*
|
1997-12-22 |
2003-07-28 |
Schering Corp |
Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
|
US6394945B1
(en)
*
|
1997-12-22 |
2002-05-28 |
Mds (Canada), Inc. |
Radioactively coated devices
|
KR100228187B1
(ko)
*
|
1997-12-24 |
1999-11-01 |
김성년 |
풍선도자 기구에 사용되는 방사성 밸룬 및 그의 제조방법
|
WO1999033473A1
(fr)
*
|
1997-12-25 |
1999-07-08 |
Toray Industries, Inc. |
Remedes contre les maladies intramedullaires
|
US6683100B2
(en)
|
1999-01-19 |
2004-01-27 |
Novartis Ag |
Organic compounds
|
ID26549A
(id)
*
|
1998-02-05 |
2001-01-18 |
Novartis Ag |
Komposisi-komposisi epotilon
|
GB9802451D0
(en)
*
|
1998-02-05 |
1998-04-01 |
Ciba Geigy Ag |
Organic compounds
|
US7030155B2
(en)
|
1998-06-05 |
2006-04-18 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
ATE211931T1
(de)
*
|
1998-06-26 |
2002-02-15 |
Quanam Medical Corp |
Topoisomerase inhibitoren zur restenose- prevention
|
US5981564A
(en)
*
|
1998-07-01 |
1999-11-09 |
Universite Laval |
Water-soluble derivatives of paclitaxel, method for producing same and uses thereof
|
US7314637B1
(en)
|
1999-06-29 |
2008-01-01 |
Neopharm, Inc. |
Method of administering liposomal encapsulated taxane
|
US7008645B2
(en)
|
1998-07-14 |
2006-03-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method of inhibiting restenosis using bisphosphonates
|
IL125336A0
(en)
*
|
1998-07-14 |
1999-03-12 |
Yissum Res Dev Co |
Compositions for inhibition and treatment of restinosis
|
US6984400B2
(en)
|
1998-07-14 |
2006-01-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method of treating restenosis using bisphosphonate nanoparticles
|
JP4898991B2
(ja)
*
|
1998-08-20 |
2012-03-21 |
クック メディカル テクノロジーズ エルエルシー |
被覆付植込式医療装置
|
US6350786B1
(en)
|
1998-09-22 |
2002-02-26 |
Hoffmann-La Roche Inc. |
Stable complexes of poorly soluble compounds in ionic polymers
|
DE19845798A1
(de)
*
|
1998-09-29 |
2000-04-13 |
Schering Ag |
Verwendung von Neoangiogenese-Markern für Diagnose und Therapie von Tumoren, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung
|
CA2358638A1
(en)
*
|
1999-01-12 |
2000-07-20 |
Quanam Medical Corporation |
Composition and methods for administration of water-insoluble paclitaxel derivatives
|
US6333347B1
(en)
*
|
1999-01-29 |
2001-12-25 |
Angiotech Pharmaceuticals & Advanced Research Tech |
Intrapericardial delivery of anti-microtubule agents
|
JP2002537324A
(ja)
*
|
1999-02-23 |
2002-11-05 |
アンジオテック ファーマシューティカルズ,インコーポレイテッド |
易感染性の体通路および体腔の完全性を改良するための組成物および方法
|
US7018654B2
(en)
*
|
1999-03-05 |
2006-03-28 |
New River Pharmaceuticals Inc. |
Pharmaceutical composition containing an active agent in an amino acid copolymer structure
|
US6716452B1
(en)
|
2000-08-22 |
2004-04-06 |
New River Pharmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
US7060708B2
(en)
|
1999-03-10 |
2006-06-13 |
New River Pharmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
US20040121954A1
(en)
*
|
1999-04-13 |
2004-06-24 |
Xu Wuhan Jingya |
Poly(dipeptide) as a drug carrier
|
US20010041189A1
(en)
*
|
1999-04-13 |
2001-11-15 |
Jingya Xu |
Poly(dipeptide) as a drug carrier
|
US6317615B1
(en)
|
1999-04-19 |
2001-11-13 |
Cardiac Pacemakers, Inc. |
Method and system for reducing arterial restenosis in the presence of an intravascular stent
|
US6368658B1
(en)
*
|
1999-04-19 |
2002-04-09 |
Scimed Life Systems, Inc. |
Coating medical devices using air suspension
|
DE60036382D1
(de)
*
|
1999-06-21 |
2007-10-25 |
Nihon Mediphysics Co Ltd |
Verfahren zur verabreichung von arzneimitteln mit bindungsaffinität zum plasmaprotein und verwendung der zusammensetzung in dem verfahren
|
US6258121B1
(en)
*
|
1999-07-02 |
2001-07-10 |
Scimed Life Systems, Inc. |
Stent coating
|
US6273901B1
(en)
|
1999-08-10 |
2001-08-14 |
Scimed Life Systems, Inc. |
Thrombosis filter having a surface treatment
|
EP1210121A2
(en)
|
1999-08-24 |
2002-06-05 |
Cellgate Inc. |
Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
|
US6669951B2
(en)
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
US7229961B2
(en)
|
1999-08-24 |
2007-06-12 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into ocular tissues
|
ATE324867T1
(de)
*
|
1999-09-09 |
2006-06-15 |
Univ California |
Verabreichung von taxanen an angiogene blutgefässe mittels kationischer liposomen
|
CN1111166C
(zh)
*
|
1999-09-10 |
2003-06-11 |
云南汉德生物技术有限公司 |
水溶性三尖杉磷碱聚氨基酸酯或其盐,含它们的药物组合物及其医药用途
|
US6713454B1
(en)
|
1999-09-13 |
2004-03-30 |
Nobex Corporation |
Prodrugs of etoposide and etoposide analogs
|
US6380405B1
(en)
|
1999-09-13 |
2002-04-30 |
Nobex Corporation |
Taxane prodrugs
|
US6541508B2
(en)
|
1999-09-13 |
2003-04-01 |
Nobex Corporation |
Taxane prodrugs
|
CA2385528C
(en)
|
1999-10-01 |
2013-12-10 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
EP1225917A2
(en)
*
|
1999-10-12 |
2002-07-31 |
Cell Therapeutics, Inc. |
Manufacture of polyglutamate-therapeutic agent conjugates
|
US20030054977A1
(en)
*
|
1999-10-12 |
2003-03-20 |
Cell Therapeutics, Inc. |
Manufacture of polyglutamate-therapeutic agent conjugates
|
US7067111B1
(en)
*
|
1999-10-25 |
2006-06-27 |
Board Of Regents, University Of Texas System |
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
|
US6692724B1
(en)
|
1999-10-25 |
2004-02-17 |
Board Of Regents, The University Of Texas System |
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
|
US6638906B1
(en)
|
1999-12-13 |
2003-10-28 |
Nobex Corporation |
Amphiphilic polymers and polypeptide conjugates comprising same
|
US6313143B1
(en)
*
|
1999-12-16 |
2001-11-06 |
Hoffmann-La Roche Inc. |
Substituted pyrroles
|
US20020077290A1
(en)
*
|
2000-03-17 |
2002-06-20 |
Rama Bhatt |
Polyglutamic acid-camptothecin conjugates and methods of preparation
|
US6362217B2
(en)
*
|
2000-03-17 |
2002-03-26 |
Bristol-Myers Squibb Company |
Taxane anticancer agents
|
PL358335A1
(en)
*
|
2000-03-17 |
2004-08-09 |
Cell Therapeutics, Inc. |
Polyglutamic acid-camptothecin conjugates and methods of preparation
|
AU2001253479A1
(en)
|
2000-04-13 |
2001-10-30 |
Sts Biopolymers, Inc. |
Targeted therapeutic agent release devices and methods of making and using the same
|
US8236048B2
(en)
|
2000-05-12 |
2012-08-07 |
Cordis Corporation |
Drug/drug delivery systems for the prevention and treatment of vascular disease
|
US6776796B2
(en)
|
2000-05-12 |
2004-08-17 |
Cordis Corportation |
Antiinflammatory drug and delivery device
|
DK1286704T3
(da)
|
2000-06-02 |
2014-09-22 |
Univ Texas |
Ethylendicystein (EC)-glucose analoge konjugater
|
JP2004501143A
(ja)
|
2000-06-22 |
2004-01-15 |
ニトロメド インコーポレーテッド |
ニトロソ化およびニトロシル化タキサン、組成物および使用方法
|
CN1125097C
(zh)
*
|
2000-07-05 |
2003-10-22 |
天津大学 |
聚乙二醇支载的紫杉醇或多烯紫杉醇的前药
|
US7163918B2
(en)
|
2000-08-22 |
2007-01-16 |
New River Pharmaceuticals Inc. |
Iodothyronine compositions
|
US20020099013A1
(en)
*
|
2000-11-14 |
2002-07-25 |
Thomas Piccariello |
Active agent delivery systems and methods for protecting and administering active agents
|
US20060177416A1
(en)
|
2003-10-14 |
2006-08-10 |
Medivas, Llc |
Polymer particle delivery compositions and methods of use
|
ES2275737T3
(es)
|
2000-09-29 |
2007-06-16 |
Cordis Corporation |
Dispositivos medicos revestidos.
|
US6616592B1
(en)
*
|
2000-11-13 |
2003-09-09 |
Isotech, L.L.C. |
Radioactive medical devices for inhibiting a hyperplastic response and method of making radioactive medical devices
|
US6612976B2
(en)
*
|
2000-11-13 |
2003-09-02 |
Isotech, L.L.C. |
Radioactive medical devices and methods of making radioactive medical devices
|
US8394813B2
(en)
|
2000-11-14 |
2013-03-12 |
Shire Llc |
Active agent delivery systems and methods for protecting and administering active agents
|
US20090306228A1
(en)
*
|
2000-11-14 |
2009-12-10 |
Shire Llc |
Active agent delivery systems and methods for protecting and administering active agents
|
CA2428971A1
(en)
*
|
2000-11-14 |
2003-05-01 |
New River Pharmaceuticals Inc. |
Conjugates of a therapeutic agent and a peptide carrier
|
WO2002041931A2
(en)
*
|
2000-11-27 |
2002-05-30 |
Medtronic, Inc. |
Stents and methods for preparing stents
|
EP1355566B1
(en)
*
|
2000-12-18 |
2012-11-28 |
Board Of Regents, The University Of Texas System |
Local regional chemotherapy and radiotherapy using in situ hydrogel
|
JP4458746B2
(ja)
*
|
2001-01-16 |
2010-04-28 |
グラクソ グループ リミテッド |
癌の治療方法
|
CA2435418A1
(en)
*
|
2001-01-24 |
2002-08-01 |
Mestex Ag |
Use of neurotoxic substances in producing a medicament for treating joint pains
|
WO2002058699A1
(en)
*
|
2001-01-25 |
2002-08-01 |
Bristol-Myers Squibb Company |
Pharmaceutical forms of epothilones for oral administration
|
IL156580A0
(en)
*
|
2001-01-25 |
2004-01-04 |
Bristol Myers Squibb Co |
A method for formulating an epothilone analog for parenteral use and pharmaceutical preparations including an epothilone analog
|
US7771468B2
(en)
*
|
2001-03-16 |
2010-08-10 |
Angiotech Biocoatings Corp. |
Medicated stent having multi-layer polymer coating
|
TWI331525B
(en)
*
|
2001-03-19 |
2010-10-11 |
Novartis Ag |
Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
|
US20020169125A1
(en)
*
|
2001-03-21 |
2002-11-14 |
Cell Therapeutics, Inc. |
Recombinant production of polyanionic polymers and uses thereof
|
DE10115740A1
(de)
*
|
2001-03-26 |
2002-10-02 |
Ulrich Speck |
Zubereitung für die Restenoseprophylaxe
|
EP1610751A4
(en)
*
|
2001-04-26 |
2006-05-24 |
Univ Texas |
AGENTE / LIGAND CONJUGATED THERAPEUTIC COMPOSITIONS, METHODS OF SYNTHESIS AND USE THEREOF
|
WO2002090390A1
(en)
*
|
2001-05-04 |
2002-11-14 |
University Of Utah Research Foundation |
Hyaluronic acid containing bioconjugates : targeted delivery of anti-cancer drugs to cancer cells
|
US7375082B2
(en)
*
|
2002-02-22 |
2008-05-20 |
Shire Llc |
Abuse-resistant hydrocodone compounds
|
US7169752B2
(en)
*
|
2003-09-30 |
2007-01-30 |
New River Pharmaceuticals Inc. |
Compounds and compositions for prevention of overdose of oxycodone
|
US7338939B2
(en)
*
|
2003-09-30 |
2008-03-04 |
New River Pharmaceuticals Inc. |
Abuse-resistant hydrocodone compounds
|
US20070066537A1
(en)
*
|
2002-02-22 |
2007-03-22 |
New River Pharmaceuticals Inc. |
Compounds and compositions for prevention of overdose of oxycodone
|
US20060014697A1
(en)
|
2001-08-22 |
2006-01-19 |
Travis Mickle |
Pharmaceutical compositions for prevention of overdose or abuse
|
US7708712B2
(en)
*
|
2001-09-04 |
2010-05-04 |
Broncus Technologies, Inc. |
Methods and devices for maintaining patency of surgically created channels in a body organ
|
WO2003035135A1
(en)
*
|
2001-09-24 |
2003-05-01 |
Boston Scientific Limited |
Optimized dosing for drug coated stents
|
JP2005507934A
(ja)
*
|
2001-10-30 |
2005-03-24 |
ネクター セラピューティックス エイエル,コーポレイション |
レチノイン酸の水溶性ポリマー結合体
|
US7488313B2
(en)
*
|
2001-11-29 |
2009-02-10 |
Boston Scientific Scimed, Inc. |
Mechanical apparatus and method for dilating and delivering a therapeutic agent to a site of treatment
|
DE10158904A1
(de)
*
|
2001-11-30 |
2003-06-12 |
Roche Diagnostics Gmbh |
Verfahren zur Herstellung von linearen DNA Fragmenten für die in vitro Expression von Proteinen
|
KR20030049023A
(ko)
*
|
2001-12-13 |
2003-06-25 |
주식회사 코오롱 |
방사선 감작제용 파클리탁셀 유도체
|
IL162118A0
(en)
*
|
2001-12-20 |
2005-11-20 |
Bristol Myers Squibb Co |
Pharmaceutical compositions containing an orally active taxane derivative
|
US7261875B2
(en)
*
|
2001-12-21 |
2007-08-28 |
Board Of Regents, The University Of Texas System |
Dendritic poly (amino acid) carriers and methods of use
|
ATE410459T1
(de)
|
2002-01-14 |
2008-10-15 |
Gen Hospital Corp |
Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung
|
KR20030068955A
(ko)
*
|
2002-02-19 |
2003-08-25 |
주식회사 코오롱 |
새로운 중간 결합체(self-immolatinglinker) 화합물과 그 제조방법, 이를 이용한파클리탁셀 또는 이의 유도체의 잔기를 포함하는 수용성프로드럭 화합물, 그의 제조방법 및 이를 유효성분으로포함하는 약제 조성물
|
US7700561B2
(en)
*
|
2002-02-22 |
2010-04-20 |
Shire Llc |
Abuse-resistant amphetamine prodrugs
|
US7105486B2
(en)
*
|
2002-02-22 |
2006-09-12 |
New River Pharmaceuticals Inc. |
Abuse-resistant amphetamine compounds
|
EP2266590A3
(en)
|
2002-02-22 |
2011-04-20 |
Shire LLC |
Active agent delivery sytems and methods for protecting and administering active agents
|
US7659253B2
(en)
|
2002-02-22 |
2010-02-09 |
Shire Llc |
Abuse-resistant amphetamine prodrugs
|
IL163667A0
(en)
*
|
2002-02-22 |
2005-12-18 |
New River Pharmaceuticals Inc |
Novel sustained release pharmaceutical compounds to preventabuse of controlled substances
|
JP2005527505A
(ja)
*
|
2002-02-22 |
2005-09-15 |
ニュー リバー ファーマシューティカルズ インコーポレイテッド |
薬物血清レベルの患者間変動性を低減するためのペプチド−薬物複合体の使用
|
US7635463B2
(en)
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
US7138105B2
(en)
|
2002-02-27 |
2006-11-21 |
Pharmain |
Compositions for delivery of therapeutics and other materials, and methods of making and using the same
|
CN100475269C
(zh)
*
|
2002-03-05 |
2009-04-08 |
北京键凯科技有限公司 |
亲水性聚合物-谷氨酸寡肽与药物分子的结合物、包含该结合物的组合物及用途
|
DE10209822A1
(de)
*
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
|
DE10209821A1
(de)
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Kopplung von Proteinen an ein modifiziertes Polysaccharid
|
AU2003221291A1
(en)
*
|
2002-03-13 |
2003-09-22 |
Beijing Jiankai Technology Co., Ltd. |
Hydrophilic polymer derivate with y type branch and preparation method of it medical composite comprising above compound
|
US20050220753A1
(en)
*
|
2002-03-22 |
2005-10-06 |
Beijing Jiankai Technology Co., Ltd |
Hydrophilic polymers-flavoids conjugates and pharmaceutical compositions comprising them
|
US7264822B2
(en)
*
|
2002-04-03 |
2007-09-04 |
Poly-Med, Inc. |
Conjugated drug-polymer coated stent
|
AU2003296878A1
(en)
*
|
2002-05-20 |
2004-12-13 |
Kosan Biosciences, Inc. |
Methods to administer epothilone d
|
EP2851097A3
(en)
|
2002-07-12 |
2015-06-10 |
Cook Medical Technologies LLC |
Drug-coated angioplasty balloons
|
DK1767535T3
(da)
|
2002-08-23 |
2010-04-12 |
Sloan Kettering Inst Cancer |
Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse
|
US7649006B2
(en)
|
2002-08-23 |
2010-01-19 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
US20040047835A1
(en)
*
|
2002-09-06 |
2004-03-11 |
Cell Therapeutics, Inc. |
Combinatorial drug therapy using polymer drug conjugates
|
EP2277551B1
(en)
|
2002-09-06 |
2013-05-08 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto
|
JP2006516534A
(ja)
*
|
2002-09-11 |
2006-07-06 |
フレセニウス・カビ・ドイッチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
Has化ポリペプチド、特にhas化エリスロポエチン
|
DE10244847A1
(de)
|
2002-09-20 |
2004-04-01 |
Ulrich Prof. Dr. Speck |
Medizinische Vorrichtung zur Arzneimittelabgabe
|
ITPD20020271A1
(it)
*
|
2002-10-18 |
2004-04-19 |
Fidia Farmaceutici |
Composti chimico-farmaceutici costituiti da derivati dei taxani legati covalentemente all'acido ialuronico o ai suoi derivati.
|
WO2004037311A2
(en)
|
2002-10-21 |
2004-05-06 |
Kensey Nash Corporation |
Device and methods for sequential, regional delivery of multiple cytotoxic agents
|
AU2003291337B2
(en)
|
2002-11-07 |
2010-09-09 |
Kosan Biosciences Incorporated |
Trans-9,10-dehydroepothilone C and D, analogs thereof and methos of making the same
|
CN1723042B
(zh)
*
|
2002-11-07 |
2010-12-01 |
得克萨斯大学体系董事会 |
乙二半胱氨酸(ec)-药物结合物、组合物及用于组织特异性疾病显像的方法
|
SI1585548T1
(sl)
|
2002-12-09 |
2018-11-30 |
Abraxis Bioscience, Llc |
Sestave in metode odmerjanja farmakoloških sredstev
|
US20050009849A1
(en)
*
|
2003-01-03 |
2005-01-13 |
Veach Darren R. |
Pyridopyrimidine kinase inhibitors
|
BRPI0407096A
(pt)
|
2003-02-03 |
2006-01-24 |
Neopharm Inc |
Taxano encapsulado em lipossomo estável, estéril e filtrável e outros fármacos antineoplásicos
|
US7311727B2
(en)
*
|
2003-02-05 |
2007-12-25 |
Board Of Trustees Of The University Of Arkansas |
Encased stent
|
RU2324701C2
(ru)
*
|
2003-03-20 |
2008-05-20 |
Ниппон Каяку Кабусики Кайся |
Мицеллярный препарат, содержащий малорастворимый в воде противораковый агент, содержащее его противораковое средство и новый блок-сополимер
|
US7306580B2
(en)
*
|
2003-04-16 |
2007-12-11 |
Cook Incorporated |
Medical device with therapeutic agents
|
KR100512483B1
(ko)
|
2003-05-07 |
2005-09-05 |
선바이오(주) |
신규한 폴리에틸렌글리콜-말레이미드 유도체의 합성방법
|
EP1475105A1
(en)
*
|
2003-05-09 |
2004-11-10 |
Schering AG |
Bone localising radiopharmaceutical and tubulin-interacting compound combinatorial radiotherapy
|
TW200427503A
(en)
*
|
2003-05-27 |
2004-12-16 |
Kureha Chemical Ind Co Ltd |
Process for producing thermoplastic resin molding
|
PT1644019E
(pt)
*
|
2003-05-29 |
2012-05-23 |
Shire Llc |
Compostos de anfetamina resistentes ao abuso
|
US20050026893A1
(en)
*
|
2003-05-30 |
2005-02-03 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with immunosuppressants
|
US20050020534A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with antimetabolites
|
US20050020556A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes
|
DE10324710A1
(de)
|
2003-05-30 |
2004-12-16 |
Supramol Parenteral Colloids Gmbh |
Stärkederivatkomplexe
|
US7691838B2
(en)
|
2003-05-30 |
2010-04-06 |
Kosan Biosciences Incorporated |
Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics
|
US20050054589A1
(en)
*
|
2003-05-30 |
2005-03-10 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with antibiotics
|
US20050020557A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with enzyme inhibitors
|
US20050054625A1
(en)
*
|
2003-05-30 |
2005-03-10 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with nuclear export inhibitors
|
US10517883B2
(en)
|
2003-06-27 |
2019-12-31 |
Zuli Holdings Ltd. |
Method of treating acute myocardial infarction
|
WO2005014655A2
(en)
*
|
2003-08-08 |
2005-02-17 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of hydroxyalkyl starch and a protein
|
US20080274948A1
(en)
*
|
2003-08-08 |
2008-11-06 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of Hydroxyalkyl Starch and G-Csf
|
US20050152979A1
(en)
*
|
2003-09-05 |
2005-07-14 |
Cell Therapeutics, Inc. |
Hydrophobic drug compositions containing reconstitution enhancer
|
EP1667726B1
(en)
|
2003-09-05 |
2011-05-04 |
The General Hospital Corporation |
Polyacetal drug conjugates as release system
|
US8394365B2
(en)
|
2003-09-17 |
2013-03-12 |
Nektar Therapeutics |
Multi-arm polymer prodrugs
|
JP5632119B2
(ja)
|
2003-09-17 |
2014-11-26 |
ウェルズ ファーゴ バンク ナショナル アソシエイション |
多分岐ポリマーのプロドラッグ
|
SG147485A1
(en)
*
|
2003-09-30 |
2008-11-28 |
Shire Llc |
Pharmaceutical compositions for prevention of overdose or abuse
|
AU2004297228A1
(en)
|
2003-12-03 |
2005-06-23 |
Nektar Therapeutics Al, Corporation |
Method of preparing maleimide functionalized polymers
|
US9050378B2
(en)
|
2003-12-10 |
2015-06-09 |
Board Of Regents, The University Of Texas System |
N2S2 chelate-targeting ligand conjugates
|
ITTO20040056A1
(it)
*
|
2004-02-05 |
2004-05-05 |
Sorin Biomedica Cardio Spa |
Stent per l'erogazione endoliminale di principi o agenti attivi
|
EP2336192A1
(en)
|
2004-03-11 |
2011-06-22 |
Fresenius Kabi Deutschland GmbH |
Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
|
EP2279752A3
(en)
*
|
2004-03-11 |
2011-08-24 |
Fresenius Kabi Deutschland GmbH |
Conjugates of hydroxyalkyl starch and a protein, prepared by native chemical ligation
|
GB0406445D0
(en)
*
|
2004-03-23 |
2004-04-28 |
Astrazeneca Ab |
Combination therapy
|
US7754897B2
(en)
|
2005-06-15 |
2010-07-13 |
Cardiome Pharma Corp. |
Synthetic processes for the preparation of aminocyclohexyl ether compounds
|
US7705036B2
(en)
|
2004-04-01 |
2010-04-27 |
Cardiome Pharma Corp. |
Deuterated aminocyclohexyl ether compounds and processes for preparing same
|
WO2005094897A2
(en)
*
|
2004-04-01 |
2005-10-13 |
Cardiome Pharma Corp. |
Pegylated ion channel modulating compounds
|
KR20050099311A
(ko)
*
|
2004-04-09 |
2005-10-13 |
에이엔에이치 케어연구소(주) |
주사제용 항암제 조성물
|
WO2006004429A2
(en)
*
|
2004-07-02 |
2006-01-12 |
Ge Healthcare As |
Imaging agents comprising a non- peptidic vector linked to a fluorophore via a polyethylene glycol linker
|
US7812051B2
(en)
|
2004-08-11 |
2010-10-12 |
Arqule, Inc. |
Pharmaceutical compositions of β-lapachone and β-lapachone analogs with improved tumor targeting potential
|
US8614228B2
(en)
|
2004-08-11 |
2013-12-24 |
Arqule, Inc. |
Quinone prodrug compositions and methods of use
|
ES2410591T3
(es)
|
2004-09-22 |
2013-07-02 |
Nippon Kayaku Kabushiki Kaisha |
Nuevo copolímero en bloque, preparación micelar y agente antineoplásico que lo contiene como principio activo
|
US8692002B2
(en)
|
2004-11-18 |
2014-04-08 |
Cardiome Pharma Corp. |
Synthetic process for aminocyclohexyl ether compounds
|
US20120269886A1
(en)
|
2004-12-22 |
2012-10-25 |
Nitto Denko Corporation |
Therapeutic agent for pulmonary fibrosis
|
CN101102795B
(zh)
|
2004-12-22 |
2011-12-07 |
日东电工株式会社 |
用于抑制纤维化的药物载体和药物载体试剂盒
|
SI3248600T1
(sl)
|
2005-02-18 |
2020-09-30 |
Abraxis Bioscience, Llc |
Kombinacije in načini dajanja terapevtskih sredstev in kombinacijska terapija
|
WO2006094810A2
(en)
*
|
2005-03-11 |
2006-09-14 |
Fresenius Kabi Deutschland Gmbh |
Production of bioactive glycoproteins from inactive starting material by conjugation with hydroxyalkylstarch
|
KR20080008364A
(ko)
*
|
2005-05-05 |
2008-01-23 |
헤모텍 아게 |
관 스텐트의 전면 코팅
|
US8574259B2
(en)
|
2005-05-10 |
2013-11-05 |
Lifescreen Sciences Llc |
Intravascular filter with drug reservoir
|
US7772177B2
(en)
|
2005-05-18 |
2010-08-10 |
Aegera Therapeutics, Inc. |
BIR domain binding compounds
|
ES2341285T3
(es)
*
|
2005-07-19 |
2010-06-17 |
Nektar Therapeutics |
Metodo para preparar maleimidas polimericas.
|
AU2006276278A1
(en)
*
|
2005-07-21 |
2007-02-08 |
Fmc Biopolymer As |
Medical devices coated with a fast dissolving biocompatible coating
|
ITPD20050242A1
(it)
|
2005-08-03 |
2007-02-04 |
Fidia Farmaceutici |
Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico
|
HUE048521T2
(hu)
*
|
2005-08-31 |
2020-08-28 |
Abraxis Bioscience Llc |
Gyengén vízoldékony gyógyszerészeti és antimikrobális hatóanyagokat tartalmazó keverékek
|
CN101291658B
(zh)
*
|
2005-08-31 |
2014-04-16 |
阿布拉科斯生物科学有限公司 |
用于制备稳定性增加的水难溶性药物的组合物和方法
|
EP1762250A1
(en)
*
|
2005-09-12 |
2007-03-14 |
Fresenius Kabi Deutschland GmbH |
Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine
|
CA2623198C
(en)
|
2005-09-22 |
2014-08-05 |
Medivas, Llc |
Bis-(a-amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
|
CA2623239C
(en)
|
2005-09-22 |
2016-07-12 |
Medivas, Llc |
Solid polymer delivery compositions and methods for use thereof
|
US7846445B2
(en)
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
CN100384419C
(zh)
*
|
2005-12-02 |
2008-04-30 |
菏泽睿鹰制药集团有限公司 |
一种埃坡霉素缓释植入组合物及应用
|
ATE465205T1
(de)
|
2005-12-05 |
2010-05-15 |
Nitto Denko Corp |
Polyglutamat-aminosäure-konjugate und verfahren
|
EP1957065A1
(en)
*
|
2005-12-06 |
2008-08-20 |
Cell Therapeutics, Inc. |
Estrogen cancer therapy
|
KR101872061B1
(ko)
|
2005-12-19 |
2018-06-27 |
파마인 코포레이션 |
치료제를 전달하기 위한 소수성 코어 담체 조성물, 이 조성물의 제조 방법 및 그 조성물의 이용 방법
|
US9572886B2
(en)
|
2005-12-22 |
2017-02-21 |
Nitto Denko Corporation |
Agent for treating myelofibrosis
|
US8834912B2
(en)
*
|
2005-12-30 |
2014-09-16 |
Boston Scientific Scimed, Inc. |
Medical devices having multiple charged layers
|
US7910152B2
(en)
*
|
2006-02-28 |
2011-03-22 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide)-based drug delivery systems with controlled release rate and morphology
|
KR20080106254A
(ko)
*
|
2006-03-28 |
2008-12-04 |
니폰 가야꾸 가부시끼가이샤 |
탁산류의 고분자 결합체
|
US8758723B2
(en)
|
2006-04-19 |
2014-06-24 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for cellular imaging and therapy
|
WO2007124700A2
(en)
*
|
2006-05-03 |
2007-11-08 |
I.Q.A., A.S. |
Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof
|
NZ572836A
(en)
|
2006-05-16 |
2011-12-22 |
Pharmascience Inc |
Iap bir domain binding compounds
|
CA2652656A1
(en)
*
|
2006-05-18 |
2007-11-29 |
Nippon Kayaku Kabushiki Kaisha |
High-molecular weight conjugate of podophyllotoxins
|
US20080051603A1
(en)
|
2006-06-15 |
2008-02-28 |
Cell Therapeutics, Inc. |
Process for the preparation of poly-alpha-glutamic acid and derivatives thereof
|
CA2656077C
(en)
|
2006-06-15 |
2014-12-09 |
Marc Mckennon |
A process for the preparation of poly-alpha-glutamic acid and derivatives thereof
|
EP1867657A1
(en)
|
2006-06-15 |
2007-12-19 |
Cell Therapeutics Europe S.R.L. |
Process for the preparation of poly-a-glutamic acid and derivatives thereof
|
US20070298069A1
(en)
*
|
2006-06-26 |
2007-12-27 |
Boston Scientific Scimed, Inc. |
Medical devices for release of low solubility therapeutic agents
|
AU2007269540B2
(en)
*
|
2006-07-05 |
2013-06-27 |
Exelixis, Inc. |
Methods of using IGF1R and Abl kinase modulators
|
WO2008026048A2
(en)
*
|
2006-08-31 |
2008-03-06 |
Wockhardt Research Centre |
Stable injectable pharmaceutical compositions of docetaxel
|
JP5548364B2
(ja)
*
|
2006-10-03 |
2014-07-16 |
日本化薬株式会社 |
レゾルシノール誘導体の高分子結合体
|
US10925977B2
(en)
*
|
2006-10-05 |
2021-02-23 |
Ceil>Point, LLC |
Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
|
EP2084310A1
(en)
*
|
2006-10-05 |
2009-08-05 |
Boston Scientific Limited |
Polymer-free coatings for medical devices formed by plasma electrolytic deposition
|
WO2008056596A1
(en)
*
|
2006-11-06 |
2008-05-15 |
Nippon Kayaku Kabushiki Kaisha |
Polymeric derivative of nucleic acid metabolic antagonist
|
EP2090607B1
(en)
*
|
2006-11-08 |
2015-05-20 |
Nippon Kayaku Kabushiki Kaisha |
Polymeric derivative of nucleic acid metabolic antagonist
|
US9700704B2
(en)
|
2006-11-20 |
2017-07-11 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
US8414910B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US8414525B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US20080276935A1
(en)
|
2006-11-20 |
2008-11-13 |
Lixiao Wang |
Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
|
US8425459B2
(en)
|
2006-11-20 |
2013-04-23 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
|
US8414526B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
|
US9737640B2
(en)
|
2006-11-20 |
2017-08-22 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US20080175887A1
(en)
|
2006-11-20 |
2008-07-24 |
Lixiao Wang |
Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
|
US8998846B2
(en)
|
2006-11-20 |
2015-04-07 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
KR100847123B1
(ko)
*
|
2006-11-22 |
2008-07-18 |
주식회사 스텐다드싸이텍 |
스텐트
|
CN101583380B
(zh)
|
2006-11-30 |
2013-07-10 |
尼克塔治疗公司 |
用于制备聚合物轭合物的方法
|
CN101209350B
(zh)
|
2006-12-30 |
2011-09-07 |
中国人民解放军军事医学科学院毒物药物研究所 |
以氨基酸为连接子的多聚谷氨酸-药物偶合物
|
MX2009007663A
(es)
|
2007-01-21 |
2009-10-13 |
Hemoteq Ag |
Dispositivo medico para el tratamiento de estenosis de pasajes corporales y para la prevencion de reestenosis inminente.
|
US20080176958A1
(en)
|
2007-01-24 |
2008-07-24 |
Insert Therapeutics, Inc. |
Cyclodextrin-based polymers for therapeutics delivery
|
US20080181852A1
(en)
*
|
2007-01-29 |
2008-07-31 |
Nitto Denko Corporation |
Multi-functional Drug Carriers
|
ES2353653T3
(es)
*
|
2007-03-06 |
2011-03-03 |
Cell Therapeutics Europe S.R.L. |
Método para determinar la cantidad de taxano conjugado en conjugados de ácido poliglutámico-taxano.
|
US8784866B2
(en)
|
2007-03-26 |
2014-07-22 |
William Marsh Rice University |
Water-soluble carbon nanotube compositions for drug delivery and medicinal applications
|
TWI407971B
(zh)
|
2007-03-30 |
2013-09-11 |
Nitto Denko Corp |
Cancer cells and tumor-related fibroblasts
|
CN104800856A
(zh)
*
|
2007-04-10 |
2015-07-29 |
日东电工株式会社 |
多功能聚谷氨酸盐药物载体
|
WO2008134528A1
(en)
*
|
2007-04-25 |
2008-11-06 |
Board Of Regents, The University Of Texas System |
Anti-cancer agent-hyaluronic acid conjugate compositions and methods
|
WO2008134088A1
(en)
|
2007-04-30 |
2008-11-06 |
Arqule, Inc. |
Hydroxy sulfonate of quinone compounds and their uses
|
PT2155255E
(pt)
|
2007-05-09 |
2013-10-15 |
Nitto Denko Corp |
Composições que incluem um composto hidrofóbico e um conjugado de poliaminoácido
|
CN101730549B
(zh)
*
|
2007-05-09 |
2015-12-09 |
日东电工株式会社 |
与铂类药物结合的聚合物
|
WO2008141110A2
(en)
*
|
2007-05-09 |
2008-11-20 |
Nitto Denko Corporation |
Polyglutamate conjugates and polyglutamate-amino acid conjugates having a plurality of drugs
|
US8252361B2
(en)
*
|
2007-06-05 |
2012-08-28 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices for local and regional treatment
|
US10092524B2
(en)
|
2008-06-11 |
2018-10-09 |
Edge Therapeutics, Inc. |
Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
|
EP2164497B1
(en)
|
2007-06-11 |
2018-08-15 |
Edge Therapeutics Inc. |
A drug delivery system for the prevention of cerebral vasospasm
|
US9192697B2
(en)
|
2007-07-03 |
2015-11-24 |
Hemoteq Ag |
Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
|
US7960336B2
(en)
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
US8933197B2
(en)
|
2007-08-15 |
2015-01-13 |
Amunix Operating Inc. |
Compositions comprising modified biologically active polypeptides
|
US8563527B2
(en)
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
JP2010539245A
(ja)
*
|
2007-09-14 |
2010-12-16 |
日東電工株式会社 |
薬物担体
|
CN101808651B
(zh)
*
|
2007-09-28 |
2013-03-27 |
日本化药株式会社 |
类固醇类的高分子结合物
|
WO2009070380A2
(en)
*
|
2007-10-03 |
2009-06-04 |
William Marsh Rice University |
Water-soluble carbon nanotube compositions for drug delivery and medical applications
|
EP2070951A1
(en)
*
|
2007-12-14 |
2009-06-17 |
Fresenius Kabi Deutschland GmbH |
Method for producing a hydroxyalkyl starch derivatives with two linkers
|
US20090169480A1
(en)
*
|
2007-12-31 |
2009-07-02 |
Industrial Technology Research Institute |
Dendritic polymers and magnetic resonance imaging contrast agent employing the same
|
US20090176892A1
(en)
|
2008-01-09 |
2009-07-09 |
Pharmain Corporation |
Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|
US8101706B2
(en)
|
2008-01-11 |
2012-01-24 |
Serina Therapeutics, Inc. |
Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
|
RU2010137032A
(ru)
*
|
2008-03-06 |
2012-04-20 |
Нитто Денко Корпорейшн (Jp) |
Конъюгаты паклитаксела с полимером и способы лечения рака
|
WO2009116509A1
(ja)
*
|
2008-03-18 |
2009-09-24 |
日本化薬株式会社 |
生理活性物質の高分子結合体
|
CN101569748B
(zh)
*
|
2008-04-30 |
2012-08-22 |
宁波大学 |
一种水溶性的紫杉醇的前药制备方法
|
CN101569747B
(zh)
*
|
2008-04-30 |
2012-08-22 |
宁波大学 |
一种聚乙二醇为载体的紫杉醇的前药制备方法
|
US9126025B2
(en)
*
|
2008-05-01 |
2015-09-08 |
Bayer Intellectual Property Gmbh |
Method of coating a folded catheter balloon
|
US9149540B2
(en)
|
2008-05-08 |
2015-10-06 |
Nippon Kayaku Kabushiki Kaisha |
Polymer conjugate of folic acid or folic acid derivative
|
JP2011162569A
(ja)
*
|
2008-05-23 |
2011-08-25 |
Nano Career Kk |
カンプトテシン高分子誘導体及びその用途
|
EP2323693B1
(en)
*
|
2008-07-30 |
2017-11-08 |
Nitto Denko Corporation |
Drug carriers
|
EP2331140B1
(en)
|
2008-08-11 |
2018-07-04 |
Nektar Therapeutics |
Multi-arm polymeric alkanoate conjugates
|
WO2010024898A2
(en)
|
2008-08-29 |
2010-03-04 |
Lutonix, Inc. |
Methods and apparatuses for coating balloon catheters
|
KR20110063457A
(ko)
|
2008-09-23 |
2011-06-10 |
넥타르 테라퓨틱스 |
대상에서의 지속적 치료 약물 농도 달성을 위한 조성물 및 방법
|
US8049061B2
(en)
|
2008-09-25 |
2011-11-01 |
Abbott Cardiovascular Systems, Inc. |
Expandable member formed of a fibrous matrix having hydrogel polymer for intraluminal drug delivery
|
US8076529B2
(en)
|
2008-09-26 |
2011-12-13 |
Abbott Cardiovascular Systems, Inc. |
Expandable member formed of a fibrous matrix for intraluminal drug delivery
|
US8226603B2
(en)
|
2008-09-25 |
2012-07-24 |
Abbott Cardiovascular Systems Inc. |
Expandable member having a covering formed of a fibrous matrix for intraluminal drug delivery
|
US8721583B2
(en)
|
2008-10-31 |
2014-05-13 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US9050070B2
(en)
|
2008-10-31 |
2015-06-09 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8731840B2
(en)
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9056047B2
(en)
|
2008-10-31 |
2015-06-16 |
The Invention Science Fund I, Llc |
Compositions and methods for delivery of frozen particle adhesives
|
US9072799B2
(en)
|
2008-10-31 |
2015-07-07 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US9060934B2
(en)
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8603496B2
(en)
|
2008-10-31 |
2013-12-10 |
The Invention Science Fund I, Llc |
Compositions and methods for biological remodeling with frozen particle compositions
|
US20100111841A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Searete Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8788211B2
(en)
|
2008-10-31 |
2014-07-22 |
The Invention Science Fund I, Llc |
Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition
|
US9060926B2
(en)
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8731841B2
(en)
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8793075B2
(en)
|
2008-10-31 |
2014-07-29 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9072688B2
(en)
|
2008-10-31 |
2015-07-07 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8485861B2
(en)
|
2008-10-31 |
2013-07-16 |
The Invention Science Fund I, Llc |
Systems, devices, and methods for making or administering frozen particles
|
US9050317B2
(en)
|
2008-10-31 |
2015-06-09 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9060931B2
(en)
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for delivery of frozen particle adhesives
|
US8725420B2
(en)
|
2008-10-31 |
2014-05-13 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8858912B2
(en)
|
2008-10-31 |
2014-10-14 |
The Invention Science Fund I, Llc |
Frozen compositions and methods for piercing a substrate
|
US20100111857A1
(en)
|
2008-10-31 |
2010-05-06 |
Boyden Edward S |
Compositions and methods for surface abrasion with frozen particles
|
US8762067B2
(en)
|
2008-10-31 |
2014-06-24 |
The Invention Science Fund I, Llc |
Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data
|
AR074584A1
(es)
|
2008-12-10 |
2011-01-26 |
Mersana Therapeutics Inc |
Formulaciones farmaceuticas de conjugados camtotecina-polimero biocompatibles biodegradables
|
MX362028B
(es)
|
2009-02-03 |
2019-01-04 |
Amunix Pharmaceuticals Inc |
Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos.
|
US8680050B2
(en)
|
2009-02-03 |
2014-03-25 |
Amunix Operating Inc. |
Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
|
US8703717B2
(en)
|
2009-02-03 |
2014-04-22 |
Amunix Operating Inc. |
Growth hormone polypeptides and methods of making and using same
|
JP5544357B2
(ja)
|
2009-05-15 |
2014-07-09 |
日本化薬株式会社 |
水酸基を有する生理活性物質の高分子結合体
|
ES2705249T3
(es)
|
2009-06-08 |
2019-03-22 |
Amunix Operating Inc |
Polipéptidos reguladores de glucosa y métodos para su producción y uso
|
US9849188B2
(en)
|
2009-06-08 |
2017-12-26 |
Amunix Operating Inc. |
Growth hormone polypeptides and methods of making and using same
|
JP2012532670A
(ja)
|
2009-07-10 |
2012-12-20 |
ボストン サイエンティフィック サイムド,インコーポレイテッド |
薬剤搬送バルーンのためのナノ結晶の使用
|
WO2011008393A2
(en)
|
2009-07-17 |
2011-01-20 |
Boston Scientific Scimed, Inc. |
Nucleation of drug delivery balloons to provide improved crystal size and density
|
BR112012004094A2
(pt)
|
2009-08-24 |
2016-03-08 |
Amunix Operating Inc |
composições de fator vii de coagulação e métodos para fazer e usar as mesmas
|
JP6220126B2
(ja)
*
|
2009-11-23 |
2017-10-25 |
セルリアン・ファーマ・インコーポレイテッド |
治療的送達のためのシクロデキストリンに基づく重合体
|
US20110160645A1
(en)
*
|
2009-12-31 |
2011-06-30 |
Boston Scientific Scimed, Inc. |
Cryo Activated Drug Delivery and Cutting Balloons
|
SG182724A1
(en)
|
2010-02-12 |
2012-08-30 |
Pharmascience Inc |
Iap bir domain binding compounds
|
WO2011119536A1
(en)
|
2010-03-22 |
2011-09-29 |
Abbott Cardiovascular Systems Inc. |
Stent delivery system having a fibrous matrix covering with improved stent retention
|
KR20130028727A
(ko)
|
2010-03-29 |
2013-03-19 |
아브락시스 바이오사이언스, 엘엘씨 |
치료제의 약물 전달 및 유효성 향상 방법
|
LT2552415T
(lt)
|
2010-03-29 |
2016-12-27 |
Abraxis Bioscience, Llc |
Vėžio gydymo būdai
|
WO2011123830A2
(en)
|
2010-04-02 |
2011-10-06 |
Amunix Operating Inc. |
Alpha 1-antitrypsin compositions and methods of making and using same
|
DE102010022588A1
(de)
|
2010-05-27 |
2011-12-01 |
Hemoteq Ag |
Ballonkatheter mit einer partikelfrei Wirkstoff-abgebenden Beschichtung
|
RU2576609C2
(ru)
|
2010-06-04 |
2016-03-10 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи |
Способы лечение рака поджелудочной железы
|
EP2590678A1
(en)
|
2010-07-09 |
2013-05-15 |
Fresenius Kabi Deutschland GmbH |
Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation
|
WO2012004007A1
(en)
|
2010-07-09 |
2012-01-12 |
Fresenius Kabi Deutschland Gmbh |
Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation
|
EP2591008A1
(en)
|
2010-07-09 |
2013-05-15 |
Fresenius Kabi Deutschland GmbH |
Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation
|
EP2590677A1
(en)
|
2010-07-09 |
2013-05-15 |
Fresenius Kabi Deutschland GmbH |
Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation
|
CN102339813A
(zh)
|
2010-07-14 |
2012-02-01 |
中国科学院微电子研究所 |
半导体结构及其制造方法
|
US8889211B2
(en)
|
2010-09-02 |
2014-11-18 |
Boston Scientific Scimed, Inc. |
Coating process for drug delivery balloons using heat-induced rewrap memory
|
JP5856069B2
(ja)
|
2010-11-17 |
2016-02-09 |
日本化薬株式会社 |
新規なシチジン系代謝拮抗剤の高分子誘導体
|
US20130331443A1
(en)
|
2010-12-22 |
2013-12-12 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of taxane-based compounds
|
WO2012088445A1
(en)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
|
CN105997890A
(zh)
|
2011-02-11 |
2016-10-12 |
优势医疗公司 |
用于改善患有蛛网膜下腔出血的人的预后的组合物和方法
|
KR101328660B1
(ko)
*
|
2011-02-28 |
2013-11-14 |
부산대학교 산학협력단 |
항암제 소라페닙을 담지한 폴리카프로락톤 고분자담지체 및 이를 이용한 약물조절 방출형 스텐트
|
KR101302698B1
(ko)
*
|
2011-02-28 |
2013-09-03 |
부산대학교 산학협력단 |
폴리하이드록시옥타노에이트와 생분해성 고분자의 블락공중합체 합성에 의한 약물담지체와 이를 이용한 비혈관계 약물방출형 치료용 스텐트.
|
KR101302703B1
(ko)
|
2011-02-28 |
2013-09-03 |
부산대학교 산학협력단 |
폴리하이드록시옥타노에이트와 생분해성 고분자의 그라프트공중합체 합성에 의한 약물담지체와 이를 이용한 비혈관계 약물방출형 치료용 스텐트
|
AU2012240131B2
(en)
|
2011-04-05 |
2017-07-20 |
Edge Therapeutics |
Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow
|
WO2012175746A1
(en)
|
2011-06-23 |
2012-12-27 |
Dsm Ip Assets B.V. |
New biodegradable polyesteramide copolymers for drug delivery
|
US9873765B2
(en)
|
2011-06-23 |
2018-01-23 |
Dsm Ip Assets, B.V. |
Biodegradable polyesteramide copolymers for drug delivery
|
CN102850301A
(zh)
*
|
2011-06-28 |
2013-01-02 |
中国人民解放军军事医学科学院毒物药物研究所 |
水溶性紫杉醇衍生物及其药物组合物及其医药用途
|
US8669360B2
(en)
|
2011-08-05 |
2014-03-11 |
Boston Scientific Scimed, Inc. |
Methods of converting amorphous drug substance into crystalline form
|
US9056152B2
(en)
|
2011-08-25 |
2015-06-16 |
Boston Scientific Scimed, Inc. |
Medical device with crystalline drug coating
|
AU2012305405B2
(en)
|
2011-09-11 |
2016-01-14 |
Nippon Kayaku Kabushiki Kaisha |
Method for manufacturing block copolymer
|
CN103083680B
(zh)
|
2011-11-07 |
2014-12-24 |
北京键凯科技有限公司 |
聚乙二醇-氨基酸寡肽-依诺替康药物结合物及其药物组合物
|
RS63870B1
(sr)
|
2012-02-15 |
2023-01-31 |
Bioverativ Therapeutics Inc |
Sastavi faktora viii i postupci za pravljenje i upotrebu istih
|
JP6383666B2
(ja)
|
2012-02-15 |
2018-08-29 |
バイオベラティブ セラピューティクス インコーポレイテッド |
組換え第viii因子タンパク質
|
KR102057356B1
(ko)
|
2012-02-27 |
2019-12-18 |
아뮤닉스 파마슈티컬스, 인크. |
Xten 콘주게이트 조성물 및 그의 제조 방법
|
WO2013146381A1
(ja)
*
|
2012-03-27 |
2013-10-03 |
テルモ株式会社 |
薬剤コート層およびこれを有する医療機器
|
CA2986512C
(en)
|
2012-04-04 |
2022-05-17 |
Halozyme, Inc. |
Combination therapy with an anti-hyaluronan agent and a tumor-targeted taxane
|
CN102614110B
(zh)
*
|
2012-04-27 |
2013-12-25 |
北京大学 |
稳定的聚乙二醇化药物型胶束组合物及其制备方法
|
US9399019B2
(en)
|
2012-05-09 |
2016-07-26 |
Evonik Corporation |
Polymorph compositions, methods of making, and uses thereof
|
CN102702140B
(zh)
*
|
2012-06-19 |
2014-05-14 |
中国医学科学院生物医学工程研究所 |
一种水溶性紫杉醇化合物的制备方法及用途
|
CN102731442B
(zh)
*
|
2012-07-18 |
2014-06-11 |
中国医学科学院生物医学工程研究所 |
一种水溶性多烯紫杉醇化合物的制备方法及用途
|
US20140094432A1
(en)
|
2012-10-02 |
2014-04-03 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
US9156781B2
(en)
|
2012-11-30 |
2015-10-13 |
Novomedix, Llc |
Substituted biaryl sulfonamides and the use thereof
|
US9993427B2
(en)
|
2013-03-14 |
2018-06-12 |
Biorest Ltd. |
Liposome formulation and manufacture
|
CN105188791B
(zh)
|
2013-05-06 |
2018-01-12 |
雅培心血管***公司 |
填充有治疗剂制剂的中空支架
|
CN103263675B
(zh)
*
|
2013-05-16 |
2015-02-11 |
湘潭大学 |
一种聚ε-己内酯负载的抗肿瘤前药及其制备方法
|
US10548953B2
(en)
|
2013-08-14 |
2020-02-04 |
Bioverativ Therapeutics Inc. |
Factor VIII-XTEN fusions and uses thereof
|
CN104721830A
(zh)
*
|
2013-12-20 |
2015-06-24 |
北京蓝贝望生物医药科技股份有限公司 |
Top肽
|
AU2015366355B2
(en)
|
2014-12-18 |
2020-05-28 |
Dsm Ip Assets B.V. |
Drug delivery system for delivery of acid sensitive drugs
|
CN107683134B
(zh)
*
|
2015-05-15 |
2021-02-23 |
珠海贝海生物技术有限公司 |
多西他赛及人血清白蛋白复合物
|
KR101726728B1
(ko)
*
|
2015-07-28 |
2017-04-14 |
주식회사 삼양바이오팜 |
고분자 담체 함유 약학 조성물의 유연물질 분석 방법
|
MX2018001497A
(es)
|
2015-08-03 |
2018-05-15 |
Bioverativ Therapeutics Inc |
Proteinas de fusion de factor ix y metodos para producirlas y usarlas.
|
US11713358B2
(en)
|
2015-08-28 |
2023-08-01 |
Amunix Pharmaceuticals, Inc. |
Chimeric polypeptide assembly and methods of making and using the same
|
CN106554330B
(zh)
*
|
2015-09-26 |
2019-07-05 |
南京友怡医药科技有限公司 |
水溶性多西他赛抗癌药物化合物及其制备方法和应用
|
CN106554329B
(zh)
*
|
2015-09-26 |
2019-07-05 |
南京友怡医药科技有限公司 |
水溶性紫杉醇抗癌药物化合物及其制备方法和应用
|
CN109415378B
(zh)
*
|
2016-05-10 |
2021-11-09 |
浙江海正药业股份有限公司 |
水溶性Epothilone衍生物及其制备方法
|
WO2017193757A1
(zh)
*
|
2016-05-10 |
2017-11-16 |
浙江海正药业股份有限公司 |
水溶性Epothilone衍生物及其制备方法
|
CN108478804B
(zh)
*
|
2018-05-08 |
2020-09-22 |
辽宁大学 |
一种聚丙烯酸-s-s-药物共聚物及其制备方法
|
WO2019222435A1
(en)
|
2018-05-16 |
2019-11-21 |
Halozyme, Inc. |
Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
|
BR112021014625A2
(pt)
*
|
2019-01-28 |
2021-10-05 |
Board Of Regents, The University Of Texas System |
Método para tratar uma doença em um sujeito mamífero, método para reduzir ou eliminar uma ou mais mutações ou anormalidades citogenéticas nas células cancerosas de um sujeito com câncer, método para diagnosticar um sujeito com uma doença proliferativa responsiva à terapia de quelação, método para diagnosticar e tratar um sujeito com uma doença proliferativa responsiva à terapia de quelação, composição farmacêutica ou combinação farmacêutica, quelante de metal, terapia anticâncer, e antioxidante e/ou mineral
|
CN112604002A
(zh)
*
|
2020-07-12 |
2021-04-06 |
苏州裕泰医药科技有限公司 |
二硫键桥连的多西他赛-脂肪酸前药及其自组装纳米粒
|
US20230277490A1
(en)
*
|
2020-07-31 |
2023-09-07 |
Cedars-Sinai Medical Center |
Glutamine as an anticancer therapy in solid tumors
|